Table 4.
ACTH stimulated hormone levels and their AUC values among different phenotypes of PCOS
| Parameters |
PHO |
OH |
PH |
PO |
P |
|---|---|---|---|---|---|
| (n = 50) | (n = 32) | (n = 23) | (n = 14) | (overall) | |
|
DHEA0 |
15.9 ± 7.9 |
19.3 ± 7.7a |
17.2 ± 7.3b |
12.2 ± 7.5 |
<0.05 |
|
DHEA30 |
23.7 ± 6.7b |
24.9 ± 6.7a |
25.5 ± 5.5a |
18.2 ± 6.4 |
<0.05 |
|
DHEA60 |
24.7 ± 6.3* |
27.2 ± 5.9b |
26.3 ± 5.2 |
21.8 ± 8.1 |
<0.05 |
|
17-OHP0 (ng/ml) |
1.6 ± 1.1 |
1.4 ± 0.7 |
1.6 ± 1.3 |
0.9 ± 0.3 |
0.078 |
|
17-OHP30 (ng/ml) |
3.7 ± 1.7b |
3.7 ± 1.2a |
3.6 ± 1.5b |
2.6 ± 1.1 |
<0.05 |
|
17-OHP60 (ng/ml) |
4.3 ± 1.9 |
4.2 ± 1.5 |
4.3 ± 1.8 |
3.1 ± 1.1 |
0.072 |
|
A40 (ng/ml) |
3.4 ± 1.9 |
3.2 ± 1.2 |
2.8 ± 0.8 |
2.2 ± 1.0 |
NS |
|
A430 (ng/ml) |
4.3 ± 2.0a |
4.3 ± 1.8b |
4.0 ± 1.3b |
2.9 ± 0.9 |
<0.05 |
|
A460 (ng/ml) |
4.7 ± 1.9a |
4.3 ± 1.7b |
4.4 ± 1.4a |
3.1 ± 1.0 |
<0.01 |
|
F0 (μg/dl) |
14.4 ± 6.3 |
14.6 ± 6.0 |
13.9 ± 5.6 |
11.6 ± 4.4 |
NS |
|
F30 (μg/dl) |
26.2 ± 4.6 |
28.6 ± 5.1 |
25.9 ± 6.1 |
25.2 ± 4.6 |
NS |
|
F60 (μg/dl) |
30.4 ± 6.7 |
32.3 ± 5.7 |
31.5 ± 5.9 |
29.5 ± 5.5 |
NS |
|
AUCDHEA (ng/ml × 60 min) |
1314 ± 390 |
1437 ± 348a |
1415 ± 297a |
1057 ± 397 |
<0.05 |
|
AUC17-OHP (ng/ml × 60 min) |
198 ± 90a |
195 ± 62a |
194 ± 85b |
140 ± 51 |
<0.05 |
|
AUCA4 (ng/ml × 60 min) |
254 ± 117a |
240 ± 93b |
230 ± 69a |
164 ± 55 |
<0.05 |
| AUCF (μg/dl × 60 min) | 1466 ± 312 | 1563 ± 298 | 1456 ± 331 | 1372 ± 253 | NS |
Results are expressed as mean ± SD. NS not significant, AUC area under the curve, PHO polycystic ovaries, oligo-anovulation and hyperandrogenism, OH oligo-anovulation and hyperandrogenism, PH polycystic ovaries and hyperandrogenism, PO polycystic ovaries and oligo-anovulation, DHEA, dehydroepiandrosterone, 17-OHP 17-hydroxyprogesterone, A4 androstenedione, F cortisol.
a P <0.01 vs. PO.
b P <0.05 vs. PO.
*P <0.05 vs. OH.